The global Parkinson’s disease treatment market is expected to grow at a CAGR of over 6% during the forecast period. The primary factors that drive the growth of the global Parkinson’s disease treatment industry include the increased incidences of Parkinson’s diseases across the globe. The increased prevalence of neurological disorders such as Parkinson’s and other diseases have encouraged the players to perform R&D activities for the development of novel and advanced treatment options. Also, various studies have been done to develop the total cure and increased effectiveness of the treatment of the disease.
In August 2019, a study was conducted by Johns Hopkins Medicine associated with Parkinson’s disease via deep brain stimulator (DBS) treatment. The DBS through electrical impulses jump starts the nerve cells that produce the dopamine to lessens muscle rigidity and tremors that are the basic symptoms of Parkinson’s disease. The research was performed on seven people to study the change in dopamine levels in the brain.
Browse the full report description of "Global Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report by Type ((Drugs (Dopamine Receptor Agonists, MAO-Inhibitors, Carbidopa-Levodopa, Catechol O-methyltransferase (COMT) Inhibitors, Anticholinergics, and Others) and Surgical Procedures (Deep Brain Stimulation, Vagus Nerve Stimulation, and Others), Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market
The researchers performed PET (Positron Emission Tomography) scan on a patient with Parkinson’s disease taking dopamine increasing medications (levodopa), using a tracer for Vesicular Monoamine Transporter 2 (VMAT2). The scans showed that, as the dopamine levels in the brain increase with levodopa, VMAT2 levels decrease, and vice versa. The researchers found that, after DBS, patients having Parkinson’s disease had fewer tremors and less rigidity, and patients showed improvement in cognitive abilities and mood, with depression scores dropping by 40%.
Further, the global Parkinson’s disease treatment market has significant players operating in the industry and providing medications and surgical procedures globally. Some of the prominent players functioning in the global Parkinson’s disease treatment market Medtronic Plc, AbbVie Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Boston Scientific Corp., Cipla Inc., Mylan NV, Novartis International AG, Eli Lilly& Co., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others. These players are significantly contributing to expanding the global Parkinson’s disease treatment market size during the forecast period.
Current Market Trends Covered in the market report:
Global Parkinson’s Disease Treatment Market – Segmentation
By Type
Global Parkinson’s Disease Treatment Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-treatment-market